What does ZYUS Life Sciences’ C$15 million LIFE offering signal about its cannabinoid pharmaceutical strategy?
ZYUS Life Sciences launches a C$15–16 million LIFE offering to advance cannabinoid drug development and regulatory execution. Find out what it signals.